75 related articles for article (PubMed ID: 9583041)
1. [Indications for axillary node dissection in breast cancers].
Lejeune V; Khadel P; Voluménie JL
J Gynecol Obstet Biol Reprod (Paris); 1998 Jan; 27(1):14-20. PubMed ID: 9583041
[TBL] [Abstract][Full Text] [Related]
2. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
3. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
4. Axillary dissection: when and how radical?
Morrow M
Semin Surg Oncol; 1996; 12(5):321-7. PubMed ID: 8873319
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
7. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer: axillary dissection--or an unnecessary procedure?].
Schäfer P
Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
[TBL] [Abstract][Full Text] [Related]
9. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
10. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
12. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
13. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
[TBL] [Abstract][Full Text] [Related]
14. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
15. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Samphao S; Eremin JM; El-Sheemy M; Eremin O
Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
[TBL] [Abstract][Full Text] [Related]
16. Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections?
Samoilova E; Davis JT; Hinson J; Brill YM; Cibull ML; McGrath P; Romond E; Moore A; Samayoa LM
Ann Surg Oncol; 2007 Aug; 14(8):2221-7. PubMed ID: 17549569
[TBL] [Abstract][Full Text] [Related]
17. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
18. Axillary staging during surgery for breast cancer.
Axelsson CK; Mouridsen HT; Düring M; Møller S
Br J Surg; 2007 Mar; 94(3):304-9. PubMed ID: 17262756
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer.
Bolwell B; Andresen S; Pohlman B; Sobecks R; Goormastic M; Rybicki L; Bell K; Kalaycio M
Bone Marrow Transplant; 2001 Apr; 27(8):843-6. PubMed ID: 11477442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]